Table of Contents Chapter 1 Overview of Hemato Oncology Testing 1.1 Definition of Hemato Oncology Testing in This Report 1.2 Commercial Types of Hemato Oncology Testing 1.2.1 ctDNA Testing 1.2.2 CTC Testing 1.2.3 Other Testing 1.3 Downstream Application of Hemato Oncology Testing 1.3.1 Hospital 1.3.2 Third Party Agency 1.3.3 Others 1.4 Development History of Hemato Oncology Testing 1.5 Market Status and Trend of Hemato Oncology Testing 2015-2026 1.5.1 China Hemato Oncology Testing Market Status and Trend 2015-2026 1.5.2 Regional Hemato Oncology Testing Market Status and Trend 2015-2026 Chapter 2 China Market Status and Forecast by Regions 2.1 Market Status of Hemato Oncology Testing in China 2015-2019 2.2 Consumption Market of Hemato Oncology Testing in China by Regions 2.2.1 Consumption Volume of Hemato Oncology Testing in China by Regions 2.2.2 Revenue of Hemato Oncology Testing in China by Regions 2.3 Market Analysis of Hemato Oncology Testing in China by Regions 2.3.1 Market Analysis of Hemato Oncology Testing in North China 2015-2019 2.3.2 Market Analysis of Hemato Oncology Testing in Northeast China 2015-2019 2.3.3 Market Analysis of Hemato Oncology Testing in East China 2015-2019 2.3.4 Market Analysis of Hemato Oncology Testing in Central & South China 2015-2019 2.3.5 Market Analysis of Hemato Oncology Testing in Southwest China 2015-2019 2.3.6 Market Analysis of Hemato Oncology Testing in Northwest China 2015-2019 2.4 Market Development Forecast of Hemato Oncology Testing in China 2020-2026 2.4.1 Market Development Forecast of Hemato Oncology Testing in China 2020-2026 2.4.2 Market Development Forecast of Hemato Oncology Testing by Regions 2020-2026 Chapter 3 China Market Status and Forecast by Types 3.1 Whole China Market Status by Types 3.1.1 Consumption Volume of Hemato Oncology Testing in China by Types 3.1.2 Revenue of Hemato Oncology Testing in China by Types 3.2 China Market Status by Types in Major Countries 3.2.1 Market Status by Types in North China 3.2.2 Market Status by Types in Northeast China 3.2.3 Market Status by Types in East China 3.2.4 Market Status by Types in Central & South China 3.2.5 Market Status by Types in Southwest China 3.2.6 Market Status by Types in Northwest China 3.3 Market Forecast of Hemato Oncology Testing in China by Types Chapter 4 China Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Hemato Oncology Testing in China by Downstream Industry 4.2 Demand Volume of Hemato Oncology Testing by Downstream Industry in Major Countries 4.2.1 Demand Volume of Hemato Oncology Testing by Downstream Industry in North China 4.2.2 Demand Volume of Hemato Oncology Testing by Downstream Industry in Northeast China 4.2.3 Demand Volume of Hemato Oncology Testing by Downstream Industry in East China 4.2.4 Demand Volume of Hemato Oncology Testing by Downstream Industry in Central & South China 4.2.5 Demand Volume of Hemato Oncology Testing by Downstream Industry in Southwest China 4.2.6 Demand Volume of Hemato Oncology Testing by Downstream Industry in Northwest China 4.3 Market Forecast of Hemato Oncology Testing in China by Downstream Industry Chapter 5 Market Driving Factor Analysis of Hemato Oncology Testing 5.1 China Economy Situation and Trend Overview 5.2 Hemato Oncology Testing Downstream Industry Situation and Trend Overview Chapter 6 Hemato Oncology Testing Market Competition Status by Major Players in China 6.1 Sales Volume of Hemato Oncology Testing in China by Major Players 6.2 Revenue of Hemato Oncology Testing in China by Major Players 6.3 Basic Information of Hemato Oncology Testing by Major Players 6.3.1 Headquarters Location and Established Time of Hemato Oncology Testing Major Players 6.3.2 Employees and Revenue Level of Hemato Oncology Testing Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Hemato Oncology Testing Major Manufacturers Introduction and Market Data 7.1 Roche 7.1.1 Company profile 7.1.2 Representative Hemato Oncology Testing Product 7.1.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Roche 7.2 Berry Genomics 7.2.1 Company profile 7.2.2 Representative Hemato Oncology Testing Product 7.2.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Berry Genomics 7.3 Burning Rock Dx 7.3.1 Company profile 7.3.2 Representative Hemato Oncology Testing Product 7.3.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Burning Rock Dx 7.4 BGI 7.4.1 Company profile 7.4.2 Representative Hemato Oncology Testing Product 7.4.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of BGI 7.5 Genetron 7.5.1 Company profile 7.5.2 Representative Hemato Oncology Testing Product 7.5.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Genetron 7.6 Haplox 7.6.1 Company profile 7.6.2 Representative Hemato Oncology Testing Product 7.6.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Haplox 7.7 Amoy Dx 7.7.1 Company profile 7.7.2 Representative Hemato Oncology Testing Product 7.7.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Amoy Dx 7.8 Genosaber 7.8.1 Company profile 7.8.2 Representative Hemato Oncology Testing Product 7.8.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Genosaber 7.9 YZY Biopharma 7.9.1 Company profile 7.9.2 Representative Hemato Oncology Testing Product 7.9.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of YZY Biopharma 7.10 Wondfo 7.10.1 Company profile 7.10.2 Representative Hemato Oncology Testing Product 7.10.3 Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Wondfo Chapter 8 Upstream and Downstream Market Analysis of Hemato Oncology Testing 8.1 Industry Chain of Hemato Oncology Testing 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Hemato Oncology Testing 9.1 Cost Structure Analysis of Hemato Oncology Testing 9.2 Raw Materials Cost Analysis of Hemato Oncology Testing 9.3 Labor Cost Analysis of Hemato Oncology Testing 9.4 Manufacturing Expenses Analysis of Hemato Oncology Testing Chapter 10 Marketing Status Analysis of Hemato Oncology Testing 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference
List of Tables Table Advantage and Disadvantage of ctDNA Testing Table Advantage and Disadvantage of CTC Testing Table Advantage and Disadvantage of Other Testing Table Consumption Volume of Hemato Oncology Testing in China by Regions 2015-2019 Table Revenue of Hemato Oncology Testing in China by Regions 2015-2019 Table Consumption Volume of Hemato Oncology Testing in China by Regions 2020-2026 Table Revenue of Hemato Oncology Testing in China by Regions 2020-2026 Table Consumption Volume of Hemato Oncology Testing in China by Types 2015-2019 Table Revenue of Hemato Oncology Testing in China by Types 2015-2019 Table Consumption Volume of Hemato Oncology Testing by Types in North China 2015-2019 Table Consumption Volume of Hemato Oncology Testing by Types in Northeast China 2015-2019 Table Consumption Volume of Hemato Oncology Testing by Types in East China 2015-2019 Table Consumption Volume of Hemato Oncology Testing by Types in Central & South China 2015-2019 Table Consumption Volume of Hemato Oncology Testing by Types in Southwest China 2015-2019 Table Consumption Volume of Hemato Oncology Testing by Types in Northwest China 2015-2019 Table Consumption Volume Forecast of Hemato Oncology Testing in China by Types 2020-2026 Table Revenue Forecast of Hemato Oncology Testing in China by Types 2020-2026 Table Demand Volume of Hemato Oncology Testing in China by Downstream Industry 2015-2019 Table Demand Volume of Hemato Oncology Testing by Downstream Industry in North China 2015-2019 Table Demand Volume of Hemato Oncology Testing by Downstream Industry in Northeast China 2015-2019 Table Demand Volume of Hemato Oncology Testing by Downstream Industry in East China 2015-2019 Table Demand Volume of Hemato Oncology Testing by Downstream Industry in Central & South China 2015-2019 Table Demand Volume of Hemato Oncology Testing by Downstream Industry in Southwest China 2015-2019 Table Demand Volume of Hemato Oncology Testing by Downstream Industry in Northwest China 2015-2019 Table Demand Volume Forecast of Hemato Oncology Testing in China by Downstream Industry 2020-2026 Table Sales Volume of Hemato Oncology Testing in China by Major Players 2015-2019 Table Revenue of Hemato Oncology Testing in China by Major Players 2015-2019 Table Headquarters Location and Established Time of Hemato Oncology Testing Major Players Table Employees and Revenue Level of Hemato Oncology Testing Major Players Table Representative Hemato Oncology Testing Product One of Roche Table Representative Hemato Oncology Testing Product Two of Roche Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Roche 2015-2019 Table Representative Hemato Oncology Testing Product One of Berry Genomics Table Representative Hemato Oncology Testing Product Two of Berry Genomics Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Berry Genomics 2015-2019 Table Representative Hemato Oncology Testing Product One of Burning Rock Dx Table Representative Hemato Oncology Testing Product Two of Burning Rock Dx Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Burning Rock Dx 2015-2019 Table Representative Hemato Oncology Testing Product One of BGI Table Representative Hemato Oncology Testing Product Two of BGI Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of BGI 2015-2019 Table Representative Hemato Oncology Testing Product One of Genetron Table Representative Hemato Oncology Testing Product Two of Genetron Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Genetron 2015-2019 Table Representative Hemato Oncology Testing Product One of Haplox Table Representative Hemato Oncology Testing Product Two of Haplox Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Haplox 2015-2019 Table Representative Hemato Oncology Testing Product One of Amoy Dx Table Representative Hemato Oncology Testing Product Two of Amoy Dx Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Amoy Dx 2015-2019 Table Representative Hemato Oncology Testing Product One of Genosaber Table Representative Hemato Oncology Testing Product Two of Genosaber Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Genosaber 2015-2019 Table Representative Hemato Oncology Testing Product One of YZY Biopharma Table Representative Hemato Oncology Testing Product Two of YZY Biopharma Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of YZY Biopharma 2015-2019 Table Representative Hemato Oncology Testing Product One of Wondfo Table Representative Hemato Oncology Testing Product Two of Wondfo Table Hemato Oncology Testing Sales, Revenue, Price and Gross Margin of Wondfo 2015-2019